PhRMA Asks Federal Judge to Block Enforcement of Maryland’s New 340B Contract Pharmacy Access Law

PhRMA filed suit against Maryland's 340B contract pharmacy access law in a federal district court.
A powerful brand-name drug industry trade organization has asked a federal district judge to block Maryland from enforcing the state’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lilly Adds Significant New Restrictions on 340B Contract Pharmacy Access; Alleges Lack of Oversight by HRSA, Pharmacies and TPAs

Lilly wordmark on top of building
Pharmaceutical giant Eli Lilly has significantly escalated its restrictions on access to 340B pricing in the contract pharmacy setting, the company announced June 19 on the drug industry vendor site 340B ESP.
Pharmaceutical giant Eli Lilly has significantly escalated its restrictions on access to 340B pricing in the contract pharmacy setting, the [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lilly Posts 340B Refund Notice for Insulin Product Humulin

Eli Lilly and Amgen announced refunds for 340B covered entities that purchased certain drugs in 2021.
Drug manufacturer Eli Lilly announced a new round of refunds for Humulin, a brand-name insulin, following a 340B ceiling price [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

It’s Official: Long-Awaited Final 340B ADR Rule Takes Effect, But Findings Still Distant

The U.S. Department of Health and Human Services' final 340B Administrative Dispute Resolution rule formally took effect on June 18.
Fourteen years after the Congressional deadline, the long-anticipated revision to the 340B Administrative Dispute Resolution (ADR) process officially took effect [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Hospital Groups Bash Novartis’ ‘Whiplash-Inducing’ Arguments in Mississippi 340B Contract Pharmacy Lawsuit

American Hospital Association logo
AHA officials penned a Medical Economics op-ed on “the truth behind growth of the 340B prescription drug program.”
Drug manufacturer Novartis uses contradictory, “whiplash-inducing” arguments in its lawsuit challenging Mississippi’s 340B contract pharmacy law, hospital groups told a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Delaware House Passes 340B Contract Pharmacy Access Bill that Adds Reporting Requirements, Removes Protections for Hospitals

The Delaware House recently passed a 340B contract pharmacy access bill that removed protections for hospitals included in a previous version.
The Delaware House late last week overwhelmingly passed a bill to prohibit drugmaker 340B contract pharmacy restrictions on grantee covered [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Despite Unanimously Passing Senate, Rhode Island Fails to Pass Contract Pharmacy Protection Bill 

The U.S. House passed a bipartisan bill Tuesday evening to streamline Medicaid enrollment for pediatric providers that would also increase reporting requirements for certain 340B providers.
A state Senate-endorsed bill that would have prohibited 340B contract pharmacy restrictions in Rhode Island failed to clear the legislature [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Sanofi Sues HHS, HRSA for Contract Details Between Covered Entities, Pharmacies

Drug manufacturer Sanofi has sued the federal government for information about contracts between covered entities and contract pharmacies.
French drugmaker Sanofi recently filed suit against federal agencies seeking details from contracts between 340B covered entities and outside pharmacies. [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Federal Judge Presses Drug Industry on Preemption Arguments During Key Hearing on Louisiana 340B Law

Attorneys representing the drug industry, the state of Louisiana, and Louisiana health centers presented oral arguments before a federal district court.
A federal judge late last week pressed drug industry attorneys on their claims that Louisiana’s 340B contract pharmacy law oversteps [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Organon Ends or Loosens 340B Contract Pharmacy Restrictions in Four More States

Drugmaker Organon fully exempted West Virginia providers from its contract pharmacy policy and loosened its restrictions in three additional states.
Organon, a spinoff of pharmaceutical giant Merck with a focus on women’s health, is now fully exempting West Virginia covered [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live